Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Summary
Third Opinion Trial Synopsis:
This study is trying to find out how long it takes for white blood cell counts to go back to normal in people with a type of cancer called multiple myeloma who get a treatment with two drugs called plinabulin and pegfilgrastim after a specific type of transplant.
This study is trying to find out how long it takes for white blood cell counts to go back to normal in people with a type of cancer called multiple myeloma who get a treatment with two drugs called plinabulin and pegfilgrastim after a specific type of transplant.
*Third Opinion AI Generated Synopsis
Trial Summary
This study will see how long it takes for white blood cell counts to return to normal in people with multiple myeloma (MM) who receive plinabulin and pegfilgrastim after undergoing an autologous hematopoietic stem cell transplant (AHCT).
This study will see how long it takes for white blood cell counts to return to normal in people with multiple myeloma (MM) who receive plinabulin and pegfilgrastim after undergoing an autologous hematopoietic stem cell transplant (AHCT).
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: